BeStock  
Stocks › LBRX

LB Pharmaceuticals LBRX

US equityMarket cap rank #3171
$34.16 −$0.10 (-0.29%)
Pre-market · Oct 8, 9:10 am ET · After hours $34.16 0.00%
Open$34.02
Prev close$34.26
Day range$34.00 – $36.57
Volume385.0K
Market cap$1.10B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$53.92M-1,009.6% YoY
Net profit-$51.60M-959.4% YoY
Diluted EPS-$1.71-687.9% YoY
Free cash flow-$37.99M-579.0% YoY
Operating cash flow-$37.63M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-14.2MSep '24$-5.1MDec '24$-5.3MMar '25$-4.9MJun '25$-3.6MSep '25$-11.5MDec '25$-19.1MMar '26$-51.6MJun '26

Diluted EPS by quarter

-4.01Sep '24-1.43Dec '24-0.24Mar '25-0.22Jun '25-0.61Sep '25-0.45Dec '25-0.67Mar '26-1.71Jun '26

Free cash flow by quarter

$-22.5MSep '24$-5.9MDec '24$-8.1MMar '25$-5.6MJun '25$-3.4MSep '25$-18.1MDec '25$-23.3MMar '26$-38.0MJun '26

Annual revenue

$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-75.0%
Return on assets-45.0%
Return on invested capital-76.9%
Current ratio15.08
Liabilities / assets8.1%
Cash & investments$327.79M
Total debt$4.37M
Net cash (debt)$323.42M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $53.92M $22.10M $30.40M $13.87M $5.25M
Selling and Admin Expenses $9.77M $7.46M $13.66M $5.39M $2.83M
-General & Admin Expense $9.77M $7.46M $13.66M $5.39M $2.83M
Research & Development $44.15M $14.65M $16.74M $8.48M $2.42M
Operating Profit -$53.92M -$22.10M -$30.40M -$13.87M -$5.25M
Net Non-Operating Interest Income (Expense) $2.97M $2.85M $3.92M $2.80M $707,000.00
Non-Operating Interest Income $2.97M $2.85M $3.92M $2.80M $707,000.00
Other Income (Expense) -$662,000.00 $200,000.00 $1.28M -$401,000.00 $983,000.00
Gain on Sale of Security -$662,000.00 $200,000.00 $1.28M -$401,000.00 $983,000.00
Pretax Profit -$51.60M -$19.05M -$25.20M -$11.47M -$3.56M
Tax $0.00 $0.00 $1,000.00 $1,000.00 $0.00
Net Profit -$51.60M -$19.05M -$25.21M -$11.47M -$3.56M
Profit from Continuing Operations -$51.60M -$19.05M -$25.21M -$11.47M -$3.56M
Net Income to Parent Company -$51.60M -$19.05M -$25.21M -$11.47M -$3.56M
Net Income to Common Stockholders -$51.60M -$19.05M -$25.21M -$11.47M -$3.56M
Basic EPS -$1.71 -$0.67 -$3.13 -$0.45 -$0.61
Diluted EPS -$1.71 -$0.67 -$3.13 -$0.45 -$0.61

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $361.69M $393.48M $312.93M $312.93M $320.75M
Total Current Assets $355.30M $389.07M $308.43M $308.43M $316.40M
Cash and Cash Equivalents & Short-Term Investments $327.79M $365.64M $295.21M $295.21M $314.48M
-Cash and Cash Equivalents $283.11M $320.68M $250.17M $250.17M $269.74M
-Short Term Investments $44.68M $44.96M $45.04M $45.04M $44.74M
Prepaid Assets $26.50M $22.65M $12.74M $12.74M –
Other Current Assets $1.01M $787,000.00 $478,000.00 $478,000.00 $1.92M
Total Non-Current Assets $6.39M $4.41M $4.50M $4.50M $4.35M
Net PPE $5.61M $3.63M $3.73M $3.73M $3.83M
-Gross PPE $6.21M $4.13M $4.15M $4.15M $4.17M
-Accumulated Depreciation -$599,000.00 -$502,000.00 -$420,000.00 -$420,000.00 -$337,000.00
Other Non-Current Assets $782,000.00 $776,000.00 $770,000.00 $770,000.00 $512,000.00
Total Liabilities $29.35M $14.79M $11.62M $11.62M $10.53M
Total Current Liabilities $23.56M $10.91M $7.44M $7.44M $6.65M
Payables $3.49M $7.12M $2.13M $2.13M $2.59M
-Accounts Payable $3.49M $7.12M $2.13M $2.13M $2.59M
Current Accrued Expenses $16.43M $1.71M $2.39M $2.39M $1.33M
Short-Term Debt and Capital Lease Obligation $844,000.00 $730,000.00 $730,000.00 $730,000.00 $730,000.00
-Current Capital Lease Obligation $844,000.00 $730,000.00 $730,000.00 $730,000.00 $730,000.00
Total Non-Current Liabilities $5.78M $3.88M $4.18M $4.18M $3.88M
Long Term Debt and Capital Lease Obligation $4.37M $2.74M $2.84M $2.84M $2.94M
-Long Term Capital Lease Obligation $4.37M $2.74M $2.84M $2.84M $2.94M
Derivative Product Liabilities $1.41M $1.14M $1.34M $1.34M $942,000.00
Total Equity $332.35M $378.69M $301.31M $301.31M $310.22M
Stockholders' Equity $332.35M $378.69M $301.31M $301.31M $310.22M
Capital Stock $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
-Common Stock $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
Additional Paid-In Capital $532.34M $527.06M $430.67M $430.67M $428.33M
Retained Earnings -$200.19M -$148.58M -$129.53M -$129.53M -$118.06M
Gains/Losses Not Affecting Retained Earnings $186,000.00 $208,000.00 $168,000.00 $168,000.00 -$53,000.00
Convertible preferred securities – – $0.00 $0.00 $0.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$37.63M -$23.29M -$35.21M -$18.10M -$3.37M
Net cash flow from continuing operations -$37.63M -$23.29M -$35.21M -$18.10M -$3.37M
Net Income from Continuing Operations -$51.60M -$19.05M -$25.21M -$11.47M -$3.56M
Gain/Loss from Continuing Operations $662,000.00 -$200,000.00 -$1.27M $409,000.00 -$983,000.00
Depreciation & Depletion & Amortization $97,000.00 $82,000.00 $321,000.00 $85,000.00 $81,000.00
Other Non-Cash Items $93,000.00 $50,000.00 $147,000.00 $47,000.00 $45,000.00
Change in Working Capital $8.29M -$6.75M -$13.65M -$9.53M -$97,000.00
-Change in Receivables -$123,000.00 $103,000.00 -$268,000.00 -$100,000.00 -$208,000.00
-Change in Prepaid Assets -$4.07M -$10.22M -$12.34M -$11.30M -$1.37M
-Change in Payables and Accrued Expense $12.54M $3.46M -$910,000.00 $1.97M $1.57M
-Change in Other Current Liabilities -$57,000.00 -$99,000.00 -$134,000.00 -$98,000.00 -$94,000.00
Net cash flow from investing $89,000.00 -$32,000.00 -$39.89M -$40,000.00 -$44.84M
Net Cash Flow from Continuing Investing Activities $89,000.00 -$32,000.00 -$39.89M -$40,000.00 -$44.84M
Net PPE Purchase and Sale -$363,000.00 -$32,000.00 -$52,000.00 -$40,000.00 $0.00
Net Investment Purchase and Sale $452,000.00 $0.00 -$39.84M $0.00 -$44.84M
Financing Cash Flow -$19,000.00 $93.83M $302.56M -$1.17M $303.73M
Net Cash Flow from Continuing Financing Activities -$19,000.00 $93.83M $302.56M -$1.17M $303.73M
Net Common Stock Issuance $0.00 $100.00M $327.75M $0.00 $327.75M
Proceeds from Stock Option Exercised $48,000.00 $29,000.00 $247,000.00 $0.00 $247,000.00
Net Other Financing Charges -$67,000.00 -$6.20M -$25.44M -$1.17M –
Ending Cash Balance $283.89M $321.45M $250.94M $250.94M $270.26M
Net Change in Cash -$37.56M $70.51M $227.47M -$19.31M $255.52M
Beginning Cash Balance $321.45M $250.94M $23.48M $270.26M $14.73M
Free Cash Flow -$37.99M -$23.32M -$35.26M -$18.14M -$3.37M
Net Preferred Stock Issuance – – $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on LBRX.

Leave a comment

Scroll to Top